Literature DB >> 9278856

Deletion of the mouse GH-binding protein (mGHBP) mRNA polyadenylation and splicing sites does not abolish production of mGHBP.

Y Zhou1, L He, G Baumann, J J Kopchick.   

Abstract

In murine species, the GH receptor (mGHR) gene encodes a full-length membrane-anchored mGHR and a truncated soluble receptor ectodomain (the GH-binding protein; mGHBP). The mGHR and mGHBP mRNAs are generated by alternative pre-mRNA splicing. Similar GHR/GHBP pairs are generated in other species by proteolysis of the GHR. The regulation of GHBP expression and the biological role of GHBP are not clear. In order to begin to dissect the factors responsible for regulating expression of mGHR and mGHBP, we have cloned a mouse GH receptor/binding protein (mGHR/BP) minigene consisting of two mGHR cDNA fragments and an mGHR/BP genomic sequence, such that the mGHR and mGHBP can be derived from the minigene by mimicking native alternative pre-mRNA splicing. To study the possible role of selection of polyadenylation relative to the expression of mGHR and mGHBP, we deleted the two tandem poly A addition signals and the flanking AT-rich region within the exon (exon 8A) that encodes the carboxy terminus of mGHBP. In addition, two other mutated forms of the minigene, one containing a mutated alternative splice acceptor site (SAS) near exon 8A and the other possessing a deletion of the intron between exons 7 and 8A (intron 7/8A), were generated. Expression of the mGHR/BP minigene and its mutated forms in transfected mouse L cells revealed that removal of the polyadenylation signals diminished but did not abolish either mGHR or mGHBP production. However, mutation of the SAS yielded normal mGHR and an mGHBP which may be a result of the translation of an mRNA possessing an open reading frame in intron 7/8A. Additionally, removal of intron 7/8A abolished mGHR expression but resulted in mGHBP production. The results suggest that selection of alternative polyadenylation sites of the mGHR/BP gene does not play a major role in the regulation of expression of mGHR and mGHBP in vitro. These results also suggest that mutation of the SAS near exon 8A does not abolish the ability of mGHR/BP gene to produce an mGHBP that retains the ability to bind GH, although the new mGHBP may be different from the natural mGHBP at its carboxy terminus.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9278856     DOI: 10.1677/jme.0.0190001

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  4 in total

1.  GHR-/- Mice are protected from obesity-related white adipose tissue inflammation.

Authors:  Jonathan A Young; Brooke E Henry; Fabian Benencia; Stephen Bell; Edward O List; John J Kopchick; Darlene E Berryman
Journal:  J Neuroendocrinol       Date:  2020-04-29       Impact factor: 3.627

2.  A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse).

Authors:  Y Zhou; B C Xu; H G Maheshwari; L He; M Reed; M Lozykowski; S Okada; L Cataldo; K Coschigamo; T E Wagner; G Baumann; J J Kopchick
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

3.  Central ghrelin regulates peripheral lipid metabolism in a growth hormone-independent fashion.

Authors:  Susana Sangiao-Alvarellos; María J Vázquez; Luis Varela; Rubén Nogueiras; Asish K Saha; Fernando Cordido; Miguel López; Carlos Diéguez
Journal:  Endocrinology       Date:  2009-07-16       Impact factor: 4.736

4.  Removal of growth hormone receptor (GHR) in muscle of male mice replicates some of the health benefits seen in global GHR-/- mice.

Authors:  Edward O List; Darlene E Berryman; Yuji Ikeno; Gene B Hubbard; Kevin Funk; Ross Comisford; Jonathan A Young; Michael B Stout; Tamar Tchkonia; Michal M Masternak; Andrzej Bartke; James L Kirkland; Richard A Miller; John J Kopchick
Journal:  Aging (Albany NY)       Date:  2015-07       Impact factor: 5.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.